Navigation Links
Medical Diagnostic Laboratories, L.L.C. Announces a Complimentary Reflex Test to Determine Azithromycin Resistance in Chlamydia Trachomatis
Date:9/11/2012

HAMILTON, N.J., Sept. 11, 2012 /PRNewswire/ -- Medical Diagnostic Laboratories, L.L.C. (MDL), a CLIA-certified infectious disease laboratory which specializes in high complexity, state-of-the-art, automated DNA-based molecular analyses, announced that it is now offering an azithromycin resistance reflex assay for Chlamydia trachomatis. MDL is believed to be the first and only clinical laboratory to offer the antibiotic resistance for this sexually transmitted pathogen. Drug resistance testing has become an essential tool to assist clinicians in the selection of appropriate drug regimens for effective treatment. The azithromycin resistance reflex assay for Chlamydia trachomatis will be performed at no additional charge when Chlamydia trachomatis is detected in a patient's specimen.

Chlamydia is the most frequently reported sexually transmitted disease in the United States and is caused by the bacterium Chlamydia trachomatis. In 2010, over 1.3 million chlamydial infections were reported to the Centers for Disease Control and Prevention (CDC) from 50 states and the District of Columbia. Asymptomatic infection is very common in both men and women and can therefore "silently" cause irreversible damage before symptoms are experienced or a proper diagnosis is made. Left untreated, a chlamydial infection can spread to a woman's uterus and fallopian tubes, and cause pelvic inflammatory disease (PID), ectopic pregnancy, and infertility.

To prevent the spread of the chlamydial infection and cure the patient, an effective treatment must be initiated as quickly as possible. Although most genital infections caused by Chlamydia trachomatis are effectively treated with azithromycin, recent studies indicate that a subset of strains are resistant to this antibiotic. This detection of resistance of Chlamydia trachomatis to azithromycin is therefore important when choosing proper antibiotic therapy. MDL has deve
'/>"/>

SOURCE Medical Diagnostic Laboratories, L.L.C.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Medical Marijuana, Inc. Portfolio Company PhytoSPHERE Systems Announces Successful Production of Hemp Harvesting for High Value CBD Oil
2. AFCell Medical Reports Results from the Retrospective Study of a Novel Allograft Membrane to Prevent Post-Operative Adhesions in the Repair of Peroneal and Posterior Tibial Tendons
3. Tufts Medical Center Announces Inaugural INNOVATION Day: Innovating a Path to Market
4. Texas Medical Center, the largest concentration of medical research, educational and healthcare organizations in the world, announces the first Houston Stem Cell Summit to highlight the latest stem cell research and commercialization efforts
5. Global Medical Laboratories Industry
6. MarketsandMarkets: Global Refurbished Medical Equipments Market worth $8.45 Billion by 2017
7. Medical Marijuana Inc. Product, CanChew Bio-Technologies
8. The Leukemia & Lymphoma Society Awards $12 Million in Research Grants in Four Critical Areas of Unmet Medical Need
9. Elsevier / MEDai Names Dr. Peter Edelstein as Chief Medical Officer and Dr. Gerald Osband as Director of Product Strategy
10. Former FDA Inspectors Train Medical Device, Pharmaceutical Companies How to Prepare for FDA Inspections of Their Quality Systems
11. Department of Defense Exercises Options Under Contract for Nerve Agent Medical Countermeasure Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Toronto, Canada (PRWEB) July 31, 2014 ... with some of the first transcriptome-wide analyses appearing ... a standard assay for RNA measurement. In the ... high throughput, more specific, work with smaller input ... special tissues (eg, blood samples). On the bioinformatics ...
(Date:7/31/2014)... Miami, Fla. (PRWEB) July 31, 2014 The ... for distribution of its monthly news magazine, Kidney Cancer News. ... have a presence on a website maintained by an international ... noted an immediate increase in viewers.” , This month’s program ... of kidney tumors analyzed in a recent study. Kidney ...
(Date:7/30/2014)... and PARIS , July 30, ... (EURONEXT: SAN and NYSE: SNY) today announced that the ... Administration (FDA) rare pediatric disease priority review voucher in ... alirocumab.  The priority review voucher entitles the holder to ... an expedited 6-month review from the filing date instead ...
(Date:7/30/2014)...  The Chicago Bears are excited to announce the ... in an effort to raise awareness of skin cancer. ... SPOT me™ skin cancer screenings at a preseason fan ... SPOT me™ is an educational campaign designed to inform ... of skin cancer, and encourages people to get screened ...
Breaking Biology Technology:The Evolution of RNA-Sequencing, Upcoming Live Webinar August 22 hosted by Xtalks 2Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 2Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 3Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 4Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 5Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 6Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 2Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 3Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 4
... N.Y., Sept. 5 BioSpecifics,Technologies Corp. (OTC Bulletin ... collagenase based products, announced today that,it has signed ... related,to its future royalty obligations for Peyronie,s disease ... one-time cash payment., BioSpecifics has modified its ...
... 4 Hologic, Inc.,(Nasdaq: HOLX ) today announced ... the Morgan Stanley Global Healthcare Unplugged,Conference being held September ... NY., Interested parties are invited to listen to ... September 9, 2008, at 1:35 PM.,Eastern Time on the ...
... COLLINS, Colo., Sept. 4 InVitria,( ... of animal free,products that enhance productivity, ... companies,in the biopharmaceutical, cell culture, life ... Sponsorship of Cambridge Healthtech,Institute,s 4th Annual ...
Cached Biology Technology:BioSpecifics Technologies Corp. Buys Down Royalties for Peyronie's Disease 2Hologic to Present at the Morgan Stanley Global Healthcare Unplugged Conference 2InVitria Sponsors Cambridge Healthtech's Optimizing Cell Culture Development Conference 2
(Date:7/31/2014)... have completed a 20-year study that looks at ... different times of the year. It finds that ... frame has no measurable negative consequences for the ... , The study was conducted by Gene Towne, ... fire chief, and Joseph Craine, research assistant professor, ...
(Date:7/31/2014)... experimental vaccine protected 100 percent of animal models against ... , which causes an intestinal disease that kills approximately ... print in Infection and Immunity . , ... non-human primates against the purified toxins produced by ... spore infection, a laboratory model that mimics the human ...
(Date:7/31/2014)... Edmond Becquerel first discovered the photovoltaic effect in 1839, ... power of sunlight for its own purposes. In a ... of the FASEB Journal , scientists ... power of sunlight by focusing on a naturally occurring ... evolution. This conservationor persistence over time and across speciessuggests ...
Breaking Biology News(10 mins):Study finds benefits to burning Flint Hills prairie in fall and winter 2Study finds benefits to burning Flint Hills prairie in fall and winter 3C. difficile vaccine proves safe, 100 percent effective in animal models 2Scientists shine bright new light on how living things capture energy from the sun 2
... that previously unrecognized substances released by algae blooms have ... interfere with the normal activity of reproductive hormones. The ... as potentially harmful to humans and aquatic animals, but ... are calling for a revision of environmental monitoring programs ...
... the establishment of the Jeffrey Modell Endowed Chair in ... at the Hospital,s Ruth and Tristram Colket, Jr. Translational ... pediatric immunologist Jordan S. Orange, M.D., Ph.D. The chair,s ... new ground in his ongoing research. Dr. Orange is ...
... the brain are characteristic features of Alzheimer disease. The ... that plays a central role in learning and memory, ... effect of tau protein is largely eliminated when the ... Max Planck Research Unit for Structural Molecular Biology at ...
Cached Biology News:Modell Chair in Pediatric Immunology established 2Tau-induced memory loss in Alzheimer's mice is reversible 2Tau-induced memory loss in Alzheimer's mice is reversible 3
Coverslips for Microarrays, 1. *Category: MICROARRAY ACCESSORIES....
S. O'Hare & C.K. Atterwill • In vitro toxicity techniques for regular lab use. Ex vivo techniques are also covered with the aim of reducing and refining the use of animals in the future....
... 2'-O-Methyltransferase converts Cap 0 (or Cap 0-like) ... 1 structure has been shown to increase ... 50%. This improvement is seen in Cap ... Capping System as well as those Cap ...
Form: Concentrated Applications: ELISA...
Biology Products: